Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Vascular purchases Peri-Guard patent:

This article was originally published in Clinica

Executive Summary

Bio-Vascular (US) has purchased the patent for Peri-Guard from Uroplasty for an undisclosed sum. The acquisition gives Bio- Vascular outright ownership and unrestricted use of Peri-Guard. Bio-Vascular also granted Uroplasty a non-exclusive, royalty-free licence for restricted use of the Peri-Guard and the Supple Peri-Guard processes in urological applications.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel